Abstract
Chlorprothixene, a thioxanthine derivative, claimed to have broad-spectrum antipsychotic properties, was compared with phenothiazine derivatives in the setting of a psychiatric admission service and aftercare clinic.
In 32 female patients with paranoid symptoms, chlorprothixene in high dosage ranges (200 to 1200 mg. daily) was found to be as effective as similar doses of chlorpromazine in controlling the symptoms; fewer side effects were noted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- FELDMAN P. E. Clinical evaluation of chlorprothixene. Am J Psychiatry. 1960 Apr;116:929–930. doi: 10.1176/ajp.116.10.929. [DOI] [PubMed] [Google Scholar]
- PELLMONT B., STEINER F. A., BESENDORF H., BAECHTOLD H. P., LAEUPPI E. [Introduction to the pharmacology of taractan, a neuroleptic with a special mechanism of action]. Schweiz Med Wochenschr. 1960 May 28;90:598–599. [PubMed] [Google Scholar]